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Modification of the standard Chlamydia trachomatis ligase chain reaction (LCR) detection assay resulted in
a quantitative test. Sample rates from C. trachomatis standards ranging from 32 to 1,048,576 elementary bodies
(EB)/ml of urine exhibited a linear correlation with concentration. Quantitative LCR (qLCR) was used to
measure the number of EB per milliliter in 158 urine samples from women in Madagascar that tested positive
for C. trachomatis by the standard LCR detection assay. C. trachomatis concentrations displayed an apparent
bimodal distribution, with approximately one-third of samples (37%) in a peak ranging from 32 to 1,015 EB/ml
(median  297 EB/ml) and the remainder (63%) in a grouping with relatively higher concentrations, ranging
from 1,086 to 218,670 EB/ml (median  7,389 EB/ml). qLCR will be useful for studies of chlamydial infection
aimed at understanding the associations of organism burden with clinical manifestations and transmission.
Sexually transmitted infection with Chlamydia trachomatis
represents a tremendous burden of disease in the United
States. Because the organism is difficult to culture, there is
little information on the relationship of organism burden to the
epidemiology of chlamydial infection and its effect on human
health. Tissue culture methods, antigen detection tests, and
DNA probe testing have poor sensitivity for chlamydial detec-
tion in clinical specimens. Recent advances in nucleic acid
amplification techniques have provided more-sensitive tests to
detect the presence of C. trachomatis infection. In addition,
they allow the use of urine rather than genital secretions for
detection. However, these tests are not designed to accurately
quantify chlamydia in clinical specimens.
Previous attempts to quantify C. trachomatis infection em-
ployed quantitative culture. Most assays rely on an indirect
estimation of an infected individual’s organism burden by a
count of the number of chlamydial inclusion-forming units in a
monolayer of tissue culture cells. These studies have been
limited by the relative insensitivity of culture (9), variability of
infectivity of host cells under different culture conditions (7,
11), and an inability to adequately quantify a broad range of
organism concentration.
Despite these limitations, several studies suggest that some
broad epidemiological factors are related to the quantity of C.
trachomatis present (1, 2, 4, 6, 10). While younger age, Cau-
casian race, oral contraception use, low secretory immunoglob-
ulin secretion and cervical ectopy appear to be related to
higher organism burdens, the associations of Chlamydia quan-
tities with gender and concurrent infection with Neisseria gon-
orrhoeae are variable. A recent study demonstrated a relation-
ship between chlamydial inclusion-forming units and clinical
manifestations of disease, such as the degree of cervicitis or
pelvic inflammatory disease in women and urethritis in men
(5). More sensitive detection and quantification methods are
needed to guide public health interventions and answer key
epidemiological questions about the transmission and patho-
genesis of this infection.
Recently, Thomas et al. (14) correlated higher values from
ligase chain reactions (LCR) in clinical samples with higher
chlamydial burdens observed by direct fluorescent antibody
testing. However, C. trachomatis was not precisely quantified in
clinical samples. In the present study, we modified the standard
LCR protocol to provide quantitative chlamydial data from
clinical urine samples over a broad range of organism concen-
trations. The assay was used to quantify C. trachomatis in urine
from infected women.
MATERIALS AND METHODS
Clinical specimens. First-catch urine was obtained in an ongoing study of
commercial sex workers in Madagascar (K. Van Damme, L. Raharimalala, N.
Ratsimbazafy, et al., Abstr. Int. Congr. Sex. Transm. Infect., p. 180, 2001).
Informed consent was obtained from all patients with approval of the Committee
for the Protection of Human Subjects at the University of North Carolina at
Chapel Hill and the Ethical Review Board of the National HIV Reference
Laboratory in Madagascar.
Preparation of C. trachomatis stock. C. trachomatis was cultivated as previously
described with slight modification (3). Briefly, McCoy cells (ATCC 1696) were
grown to near confluence in Dulbecco’s modified medium supplemented with
5% fetal bovine serum, 25 mM HEPES, 2 mM L-glutamine, and gentamicin (10
g/ml) at 37°C in 5% CO2. McCoy cell division was arrested with cycloheximide
as described previously (3). C. trachomatis serovar E elementary bodies (EB)
(generously provided by Priscilla B. Wyrick, East Tennessee State University)
were added and incubated for 48 to 72 h at 35°C. The contents of several culture
flasks were pooled, sonicated for 5 min, and centrifuged at 500  g for 10 min at
4°C to remove cellular debris. The supernatant was centrifuged at 10,000  g for
30 min at 4°C; the resulting pellet was resuspended in buffer containing sucrose,
phosphate, and glutamate (2-SPG). EB were isolated from this crude C. tracho-
matis preparation by purification over a Renografin gradient. Purified EB were
suspended in 2-SPG, aliquoted, and stored at 80°C.
Quantification of C. trachomatis stock solution. Purified EB were thawed at
37°C and sonicated on ice for 5 min. The concentration of C. trachomatis EB was
determined by direct microscopic count using a fluorescein-labeled monoclonal
antibody as previously described (8). Briefly, 10 l of a 1:4 dilution of EB stock
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solution was placed into 6-mm-diameter wells on a Teflon-coated slide (catalog
no. 63424-06; Electron Microscopy Sciences), air dried, and fixed with 70%
ethanol–30% acetone for 10 min. Wells were incubated with 15 l of fluorescein
isothiocyanate-labeled antichlamydia antibody (chlamydia confirmation kit [cat-
alog no. 8H0194]; Wompole Labs) for 30 min at 37°C; slides were rinsed and
allowed to air dry in the dark.
Immediately after staining, slides were viewed using a Zeiss LSM210 confocal
laser scanning microscope in epifluorescence mode with a magnification of
1,000. Nine fields were counted for each well; seven individual wells on four
independent slides were examined. The area per high-power field (hpf) was
determined using a stage micrometer. The mean number of organisms per hpf
was determined for each well and averaged for seven wells. The stock concen-
tration of EB per milliliter was determined using the following formula: (average
no. of EB per hpf)  (area of individual well)  (reciprocal dilution of stock) 
1,000/(area per hpf)  (volume of sample [in microliters]).
Preparation of quantitative standards. For quantitative LCR (qLCR), three
overlapping series of twofold dilutions of C. trachomatis stock solution were
prepared in pooled urine from uninfected volunteers. Several diluents were
tested by using the standard LCR urine sample preparation procedure (Abbott
LCx probe system); pooled urine resulted in higher rates by LCR than did 2-SPG
or phosphate-buffered saline. Low-range standards contained 3.2  101 to 1.0 
103 EB/ml, medium-range standards contained 5.1  102 to 3.3  104 EB/ml, and
high-range standards contained 1.6  104 to 1.0  107 EB/ml. When necessary,
a medium-low-range standard with 1.3  102 to 4.1  103 EB/ml or a high-
medium-range standard containing 4.1  103 to 1.0  103 EB/ml was used. C.
trachomatis stock solutions and LCR preparations that were frozen and thawed
up to 20 times prior to qLCR testing showed no significant decrease in LCR rate.
To maximize uniformity of individual test runs, an initial stock was quantified
microscopically, aliquoted into multiple-use vials, and frozen at 80°C. Dilutions
were made from a freshly thawed stock solution and prepared according to the
LCR urine protocol. For each qLCR run, an appropriate standard dilution series
was amplified with clinical specimens.
qLCR. Clinical urine specimens were screened using the Abbott LCx probe
system according to the manufacturer’s instructions. For qLCR, positive urine
specimens were prepared according to the standard LCR protocol and amplified
alongside a medium-standard series for 30 cycles of the otherwise-standard
thermocycler profile. The log2 of the LCR rate was plotted against the concen-
tration of each standard, and linear regression was used to generate the equation
of the line. A valid qLCR run was defined as one for which there was an
increasing LCR sample rate for each standard in the series and the R2 of the
regression line was 0.900. Chlamydia concentrations in clinical specimens were
calculated from the equation of the standard line.
To verify the reproducibility of LCR with altered cycle numbers, five prepa-
rations were made from a clinical urine sample that tested positive for C.
trachomatis by the standard LCR. Each preparation was amplified using 30
cycles, and one preparation was tested five different times. There was minimal
variation between preparations and between tests with the same preparation.
Samples that fell outside the linear range of the medium-standard series were
retested using the low-standard series at 35 amplification cycles or the high-
standard series at 25 cycles, as appropriate. In rare instances, LCR sample rates
were not squarely within the medium-standard or the subsequent series. These
samples were analyzed with an intermediate series, 33 cycles for the medium-
low-range standard series or 28 cycles for the high-medium-range standard
series.
Statistical analysis. Descriptive statistics and linear and polynomial regression
were performed using SigmaStat software (version 2.03; SPSS, Inc.).
RESULTS
LCR conditions routinely used for C. trachomatis detection
are designed to maximize sensitivity and do not provide quan-
titative information about the concentration of C. trachomatis
organisms in clinical specimens. We modified the standard
protocol by altering the number of amplification cycles, result-
ing in a linear relationship between the LCR result (log2 rate)
and the concentration of C. trachomatis as determined by di-
rect microscopy. The range of C. trachomatis concentrations
quantifiable by this method is shown in Fig. 1. The lower limit
of quantification in the assay was 32 EB/ml of urine.
qLCR of clinical specimens. Urine was obtained in an on-
going study of commercial sex workers in Madagascar as de-
scribed in Materials and Methods. Specimens from 1,000
women were screened for C. trachomatis using standard LCR.
One hundred fifty-eight specimens were confirmed positive for
C. trachomatis by standard LCR and underwent qLCR testing.
In order to demonstrate the need to modify the qualitative
protocol for quantitative analysis, the relationship between the
output from the standard LCR assay and the qLCR results, the
ratio of the sample rate to the cutoff value (S/CO, an internally
standardized value calculated automatically by the Abbott LCx
analyzer), was plotted against C. trachomatis concentration for
each specimen. Incremental polynomial regression analysis
suggested that the relationship followed second-order kinetics,
with an R of 0.615. The scatter plot and regression line for the
quadratic equation are shown in Fig. 2. The relationship be-
tween S/CO and organism burden was approximately linear at
lower C. trachomatis concentrations (less than 1,000 EB/ml of
urine) and plateaued at higher concentrations. The highest
concentration for samples with an S/CO value of 2 was 140
EB/ml of urine. This demonstrates that the degree of amplifi-
cation provided by the qualitative test shifted the values for the
higher concentrations to the asymptotic portion of the sigmoid
curve. The higher correlation coefficient of the qLCR method
suggests that the quantitative standards provided a better es-
timate for quantification than the internal standards of the
qualitative LCR assay.
The distribution of C. trachomatis concentrations in urine
from this population is shown in Fig. 3. Fifteen samples were
confirmed positive for C. trachomatis by standard LCR but
were below the quantifiable limit of qLCR. The median con-
centration of quantifiable samples was 2.17  103 EB/ml
(range  3.2  101 to 2.19  105 EB/ml). Quantifiable
samples displayed an apparent bimodal distribution. Thirty-
FIG. 1. Linear regression of representative qLCR standard curves.
Low-range standards were amplified through 35 cycles (R2  0.95),
medium-range standards were amplified through 30 cycles (R2  0.99),
and high-range standards were amplified through 25 cycles (R2  0.97)
as described in Materials and Methods.
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seven percent (53 of 143) of samples were in the lower peak
(range  3.2  101 to 1.02  103 EB/ml; median  3.2  102
EB/ml), whereas 63% (90 of 143) had relatively higher con-
centrations (range  1.1  103 to 2.19  105 EB/ml; median 
7.39  103 EB/ml).
DISCUSSION
The development of a reliable quantitative technique to
measure the clinical burden of C. trachomatis infection will
facilitate further advances in epidemiological investigations of
this prevalent sexually transmitted infection. qLCR is a repro-
ducible method for determining organism burden in clinical
samples that uses available nucleic acid amplification technol-
ogy and avoids technically difficult and variable tissue culture
techniques. The advantages of an amplification technique over
semiquantitative tissue culture techniques are several. C. tra-
chomatis culture is still required to prepare quantitative stan-
dards; however, microscopic quantification following culture
allows for quality control of the standards, whereas potential
loss of organisms with direct culture of clinical specimens is
difficult to assess. Large numbers of samples can be analyzed
by qLCR faster than with culture-based methods. Finally, by
using different standard curves, a broad range of organism
concentrations can be quantified.
Despite these advantages, qLCR is not without limitations.
The most significant may be the use of urine to assess genital
organism burden. Specimen volume can influence the amount
of chlamydia recovered in first-void urine. The use of urine as
a surrogate for cervical or urethral swabs has become accept-
able for diagnosis but is so far untested for quantification. To
correlate infectivity with quantitative C. trachomatis testing,
cervical or vaginal vault sampling may provide a better assess-
ment for women. For men, infectivity is likely related to the
chlamydia concentration in semen; however, inhibitors of the
LCR are a potential complication. Additional studies are re-
quired to quantify C. trachomatis in semen as well as to corre-
late results of qLCR using urine and those of qLCR using
genital specimens from men and women.
Variation in copy number for the plasmid containing the
LCR target is also a potential source of error in this assay. C.
trachomatis strains maintain 7 to 10 copies of this plasmid (12,
13); this range could introduce less than a twofold error in the
measured concentration. In addition, a clinical isolate lacking
this plasmid entirely has been reported (13). The extent to
which similar isolates might occur would obviously impact the
utility of both standard LCR and qLCR with the current prim-
ers.
Studies to quantify C. trachomatis in partners of infected
persons may provide evidence of the importance of organism
burden in transmission. The amount of chlamydia present in
symptomatic versus asymptomatic women and in prevalent
versus incident disease could have great public health impor-
tance. Moreover, determining the relationship between chla-
mydial concentration and clinical presentation will shed light
on the immunology of this infection. This could lead to a better
understanding of asymptomatic disease and its role in perpet-
uating chlamydial infections in populations; the development
of significant morbidity, such as pelvic inflammatory disease,
chronic abdominal pain, and infertility; and the increased risk
of transmission of human immunodeficiency virus from coin-
fected persons.
Given the limited resources available for the prevention and
control of chlamydial infection, a better understanding of the
epidemiology of the transmission cycle is essential to develop
better strategies to decrease the burden of this infection. qLCR
FIG. 2. Comparison of standard LCR S/CO values and qLCR re-
sults from clinical urine specimens from Malagasy women. The solid
line is the second-order-regression line (R  0.615); dotted lines rep-
resent the 95% confidence intervals of the regression line.
FIG. 3. Histogram of the distribution of qLCR values obtained
with clinical urine specimens from Malagasy women. The numbers
above the bars indicate the number of specimens with values in the
range of concentrations indicated on the x axis.
VOL. 40, 2002 C. TRACHOMATIS QUANTITATIVE LCR 3633
should be a useful tool to assess these strategies and to pursue
cost-effective interventions.
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